Select barriers to harm-reduction services for IDUs in eastern Europe

Nadja Kehler Curth, Liv Nanna Hansson, Frederikke Storm, Jeff Lazarus

    Research output: Contribution to journalJournal articleResearchpeer-review

    9 Citations (Scopus)

    Abstract

    In eastern Europe, the high prevalence rates of HIV and the hepatitis C virus (HCV) are concentrated among injecting drug users (IDUs). Harm reduction programmes such as needle and syringe programmes and opioid substitution therapy (OST) have been shown to be effective in preventing these infections. However, structural barriers can limit their effectiveness by hindering access.
    Original languageEnglish
    JournalCentral European Journal of Public Health
    Volume17
    Issue number4
    Pages (from-to)191-7
    Number of pages7
    ISSN1210-7778
    Publication statusPublished - 1 Dec 2009

    Keywords

    • Age Factors
    • Confidentiality
    • Europe, Eastern
    • Fees and Charges
    • HIV Infections
    • Harm Reduction
    • Health Services Accessibility
    • Hepatitis C
    • Humans
    • Methadone
    • Needle-Exchange Programs
    • Pilot Projects
    • Prevalence
    • Substance Abuse, Intravenous

    Cite this